Israeli Biotechnology Research Ltd.
Established in 1995, Israeli Biotechnology Research Ltd. (IBR) develops, manufactures and sells innovative and proprietary natural active ingredients for the cosmetic, food and pharmaceutical industries. IBR performs its research and development activities at its own laboratories and markets its cosmetics ingredient products through a network of locally appointed distributors and representatives. IBR benefits from consultancy in a variety of domains by worldwide leading researchers both in the Industry and in Academy.
Dr Fabien Havas will lead the IBR team within DISCO. He has been with IBR since 2010, and plays the role of head of R&D and formulator in IBR’s discovery and development of novel botanical active materials for the cosmetic and food supplements industries.
The colorless carotenoids phytoene and phytofluene (“IBR-Phyto(flu)ene®”) being one of IBR’s key product technology platforms, IBR’s participation in DISCO is a natural match. Within the DISCO project IBR will develop active ingredients containing phytoene, phytofluene, and other carotenoids as well as industrial end-use applications for said active ingredients, for the fields of cosmetics and dietary supplements.